Liberator Medical Holdings, Inc. is a direct-to-consumer provider of medical supplies, primarily to Medicare-eligible seniors. The Company's segment includes Mail Order Supplies. The Company markets its products to individuals with chronic illnesses who require continuous access to medical devices and supplies. It is a quasi-medical distributor providing home healthcare services. The Company distributes products that are classified as durable medical equipment (DME). It offers urological catheters, ostomy supplies, mastectomy fashions and diabetic supplies. It offers female intermittent catheters, indwelling female catheters and external catheters. It offers ostomy supplies, including colostomy, ileostomy and urostomy supplies. Its diabetes testing supplies include glucose meters, glucose test strips, control solution and lancets, offering diabetes testing supplies from the diabetes supply manufacturers. The Company offers mastectomy bras and mastectomy breast forms.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Symbol: NYSEMKT:LBMH
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $3.34
- 200 Day Moving Avg: $2.72
- 52 Week Range: $1.96 - $3.90
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 19.71
- P/E Growth: 0.00
- Average Volume: 347,035 shs.
Frequently Asked Questions for Liberator Medical Holdings (NYSEMKT:LBMH)
What is Liberator Medical Holdings' stock symbol?
Liberator Medical Holdings trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "LBMH."
How were Liberator Medical Holdings' earnings last quarter?
Liberator Medical Holdings Inc (NYSEMKT:LBMH) announced its earnings results on Monday, February, 9th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.05. View Liberator Medical Holdings' Earnings History.
Who are some of Liberator Medical Holdings' key competitors?
Some companies that are related to Liberator Medical Holdings include Becton Dickinson and Co (BDX), Baxter International (BAX), C R Bard (BCR), Mettler-Toledo International (MTD), DENTSPLY SIRONA (XRAY), Waters (WAT), Cooper Companies (COO), Teleflex Incorporated (TFX), West Pharmaceutical Services (WST), Hill-Rom Holdings (HRC), Integra Lifesciences Holdings Corp (IART), ProShares UltraShort DJ-UBS Commodity (CMD), ICU Medical, Incorporated (ICUI), Insulet (PODD), Haemonetics (HAE), Inogen (INGN), Merit Medical Systems (MMSI) and Halyard Health (HYH).
How do I buy Liberator Medical Holdings stock?
Shares of Liberator Medical Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Liberator Medical Holdings stock cost?
One share of Liberator Medical Holdings stock can currently be purchased for approximately $3.35.
Consensus Ratings for Liberator Medical Holdings (NYSEMKT:LBMH) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Liberator Medical Holdings (NYSEMKT:LBMH)
(Data available from 5/27/2015 forward)
|10/29/2015||Singular Research||Initiated Coverage||Buy||$3.60|
Earnings History for Liberator Medical Holdings (NYSEMKT:LBMH)Earnings History by Quarter for Liberator Medical Holdings (NYSEMKT:LBMH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Liberator Medical Holdings (NYSEMKT:LBMH)
Current Year EPS Consensus Estimate: $0.17 EPS
Next Year EPS Consensus Estimate: $0.17 EPS
Dividend History by Quarter for Liberator Medical Holdings (NYSEMKT:LBMH)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Liberator Medical Holdings (NYSEMKT:LBMH)Insider Trades by Quarter for Liberator Medical Holdings (NYSEMKT:LBMH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/21/2016||Bard C. R. Inc /Nj/||Major Shareholder||Buy||1,000||$0.01||$10.00|| |
|2/17/2015||Millennium Partners, L.P.||Major Shareholder||Sell||416,200||$3.66||$1,523,292.00|| |
|2/12/2015||Millennium Partners, L.P.||Major Shareholder||Sell||200,000||$3.54||$708,000.00|| |
|2/6/2015||Millennium Partners, L.P.||Major Shareholder||Sell||175,000||$3.43||$600,250.00|| |
|1/30/2015||Millennium Partners, L.P.||Major Shareholder||Sell||75,000||$3.27||$245,250.00|| |
|1/28/2015||Millennium Partners, L.P.||Major Shareholder||Sell||100,000||$3.17||$317,000.00|| |
|1/15/2015||Millennium Partners, L.P.||Major Shareholder||Sell||50,000||$3.15||$157,500.00|| |
|6/27/2014||Millennium Partners, L.P.||Major Shareholder||Sell||100,000||$4.00||$400,000.00|| |
|6/24/2014||Millennium Partners, L.P.||Major Shareholder||Sell||175,000||$4.05||$708,750.00|| |
|1/21/2014||Millennium Partners, L.P.||Major Shareholder||Sell||85,000||$5.99||$509,150.00|| |
|1/17/2014||Millennium Partners, L.P.||Major Shareholder||Sell||210,000||$5.72||$1,201,200.00|| |
|1/15/2014||Millennium Partners, L.P.||Major Shareholder||Sell||649,079||$5.19||$3,368,720.01|| |
|1/9/2014||Millennium Partners, L.P.||Major Shareholder||Sell||279,123||$4.67||$1,303,504.41|| |
|12/24/2013||Millennium Partners, L.P.||Major Shareholder||Sell||100,000||$4.36||$436,000.00|| |
|11/29/2013||Millennium Partners, L.P.||Major Shareholder||Sell||75,000||$3.65||$273,750.00|| |
|11/25/2013||Millennium Partners, L.P.||Major Shareholder||Sell||180,000||$3.20||$576,000.00|| |
|10/14/2013||Millennium Partners, L.P.||Major Shareholder||Sell||240,000||$2.20||$528,000.00|| |
|9/17/2013||Millennium Partners, L.P.||Major Shareholder||Sell||215,000||$2.25||$483,750.00|| |
|8/21/2013||Robert Joseph Davis||CFO||Buy||1,000||$1.49||$1,490.00|| |
|7/15/2013||Millennium Partners, L.P.||Major Shareholder||Sell||300,000||$1.83||$549,000.00|| |
|4/22/2013||Jeannette Maria Corbett||Director||Buy||20,000||$1.05||$21,000.00|| |
Headline Trends for Liberator Medical Holdings (NYSEMKT:LBMH)
Latest Headlines for Liberator Medical Holdings (NYSEMKT:LBMH)
No headlines for this company have been tracked by MarketBeat.com